Swedes Explain Why They Should Have the EMA ‘Gem’ After Brexit
Executive Summary
Sweden explains the reasons why the European Medicines Agency should move there from London once the UK leaves the EU, citing an established life sciences network, a strong R&D sector, and a solid biopharmaceutical industry base.
You may also be interested in...
Race Hots Up For EMA After Brexit
France has officially named Lille as the city it would like to host the European Medicines Agency once the UK leaves the EU, and Italy has appointed an ambassador to promote Milan’s bid for the agency. Meanwhile, stakeholders in Denmark are joining forces to stress why Copenhagen would be a good choice, and Ireland, the Netherlands and Austria have all confirmed their candidacies.
‘Virtually Bribery And Corruption Free’ Denmark With Its Clean Canals Says ‘Give Us EMA’
The UK is on track to start formal EU exit negotiations in March, Denmark has announced its official candidacy to host the European Medicines Agency post-Brexit, and details are emerging on the campaigns that other contenders for the EMA, such as Ireland and Italy, are waging.
EMA Post-Brexit: 'It Can’t Stay In The UK' … Or Can It?
The assumption to date has been that the European Medicines Agency will have to move from its London base when the UK leaves the EU. But things may not be quite that simple.